Celldex Therapeutics

Celldex Therapeutics is a biopharmaceutical company focused on developing targeted therapeutics to address devastating diseases, primarily cancer and inflammatory conditions. They generate revenue through the development, licensing, and commercialization of their proprietary drug candidates. Founded in 1983, Celldex has a rich history of innovation, including the development of advanced immunotherapies and precision medicine approaches. Their pipeline includes several promising candidates in various stages of clinical trials, reflecting their commitment to improving patient outcomes through cutting-edge science.

Recent Posts by Celldex Therapeutics

1-8 of 8